Ye L - Search Results

1

Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair.

Ye L, Haider HKh, Tan R, Su L, Law PK, Zhang W, Sim EK. Ye L, et al. Biomaterials. 2008 May;29(13):2125-37. doi: 10.1016/j.biomaterials.2008.01.014. Epub 2008 Feb 14. Biomaterials. 2008. PMID: 18279953

2

Skeletal myoblast transplant in heart failure.

Sim EK, Jiang S, Ye L, Lim YL, Ooi OC, Haider KH. Sim EK, et al. Among authors: ye l. J Card Surg. 2003 Jul-Aug;18(4):319-27. doi: 10.1046/j.1540-8191.2003.02033.x. J Card Surg. 2003. PMID: 12869179 Review.

3

High efficiency transduction of human VEGF165 into human skeletal myoblasts: in vitro studies.

Ye L, Haider HKh, Jiang S, Ge R, Law PK, Sim EK. Ye L, et al. Exp Mol Med. 2003 Oct 31;35(5):412-20. doi: 10.1038/emm.2003.54. Exp Mol Med. 2003. PMID: 14646595

4

Angiomyogenesis using human myoblast carrying human VEGF165 for injured heart.

Ye L, Haider KH, Jiang SJ, Ling LH, Niagara MI, Rufaihah AJ, Law PK, Sim EK. Ye L, et al. Ann Acad Med Singap. 2003 Sep;32(5 Suppl):S21-3. Ann Acad Med Singap. 2003. PMID: 14968722 No abstract available.

5

Immunosuppression and xenotransplantation of cells for cardiac repair.

Haider HKh, Ye L, Jiang S, Law PK, Sim EK. Haider HKh, et al. Among authors: ye l. Ann Thorac Surg. 2004 Mar;77(3):1133; author reply 1133-4. doi: 10.1016/S0003-4975(03)01425-5. Ann Thorac Surg. 2004. PMID: 14992952 No abstract available.

6

Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair.

Haider HKh, Jiang SJ, Ye L, Aziz S, Law PK, Sim EK. Haider HKh, et al. Among authors: ye l. Transplant Proc. 2004 Jan-Feb;36(1):232-5. doi: 10.1016/j.transproceed.2003.11.001. Transplant Proc. 2004. PMID: 15013354

7

Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor.

Haider HKh, Ye L, Jiang S, Ge R, Law PK, Chua T, Wong P, Sim EK. Haider HKh, et al. Among authors: ye l. J Mol Med (Berl). 2004 Aug;82(8):539-49. doi: 10.1007/s00109-004-0546-z. Epub 2004 Jun 3. J Mol Med (Berl). 2004. PMID: 15175859

8

Therapeutic angiogenesis using vascular endothelial growth factor.

Ye L, Haider HK, Jiang SJ, Sim EK. Ye L, et al. Asian Cardiovasc Thorac Ann. 2004 Jun;12(2):173-81. doi: 10.1177/021849230401200221. Asian Cardiovasc Thorac Ann. 2004. PMID: 15213090 Review.

9

Autologous skeletal myoblasts transduced with a new adenoviral bicistronic vector for treatment of hind limb ischemia.

Niagara MI, Haider HKh, Ye L, Koh VS, Lim YT, Poh KK, Ge R, Sim EK. Niagara MI, et al. Among authors: ye l. J Vasc Surg. 2004 Oct;40(4):774-85. doi: 10.1016/j.jvs.2004.07.027. J Vasc Surg. 2004. PMID: 15472608 Free article.

10

In vitro functional assessment of human skeletal myoblasts after transduction with adenoviral bicistronic vector carrying human VEGF165 and angiopoietin-1.

Ye L, Haider HKh, Jiang S, Ge R, Law PK, Sim EK. Ye L, et al. J Heart Lung Transplant. 2005 Sep;24(9):1393-402. doi: 10.1016/j.healun.2004.06.004. J Heart Lung Transplant. 2005. PMID: 16143262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,599 results

Search Page

Filters